Loss of PPP2R2A enhanced toxicity of A3A in HMCES KO cells (Fig 6B and 6C), and depletion or PPP2R2A was shown to enhance the toxicity of ATR-CHK1 or PARP inhibitors in NSCLC [86,87]. Here, ATR is linked to non-small cell lung carcinoma.